• Home
  • Solutions
  • vSource-rSDV

The coronavirus disease 2019 (COVID-19) pandemic has rapidly challenged the pharmaceutical industry to implement remote clinical trials. The industry’s lack of extensive experience with remote measurements initiates multiple questions about how to select candidates for remote collection, their validity, and regulatory implications of moving certain assessments to a remote mode. We propose a decision tree for migration of clinic to remote assessments and highlight activities required to ensure that these measurements are valid, safe, and usable.

  • Secured file storage & access controlled data review
  • Time bound access
  • Portability of data
  • Real-time data integration for an efficient monitoring process
  • Online portal with predefined actions as per the needs of the research team
  • 21 CFR part 11 validated system
  • User-friendly interface and functions for CRAs, Site staff, Investigators to quickly gain access to required data.
  • Our solution maintains data integrity.
  • You can lower trial costs and mitigate risks through improved decision-making.
  • Collaboration becomes easier when the ability to track the progress of the clinical trials requires lesser effort.